Cornerstone Advisory LLC lessened its holdings in BlackRock Health Sciences Trust (NYSE:BME – Free Report) by 56.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 61,205 shares of the company’s stock after selling 78,190 shares during the period. Cornerstone Advisory LLC’s holdings in BlackRock Health Sciences Trust were worth $2,279,000 at the end of the most recent reporting period.
Several other hedge funds have also recently bought and sold shares of BME. Royal Bank of Canada lifted its stake in shares of BlackRock Health Sciences Trust by 0.5% in the first quarter. Royal Bank of Canada now owns 143,546 shares of the company’s stock worth $5,546,000 after buying an additional 684 shares during the last quarter. Jones Financial Companies Lllp bought a new position in BlackRock Health Sciences Trust in the 1st quarter worth approximately $386,000. HBK Sorce Advisory LLC lifted its holdings in shares of BlackRock Health Sciences Trust by 27.1% during the second quarter. HBK Sorce Advisory LLC now owns 11,602 shares of the company’s stock worth $423,000 after buying an additional 2,476 shares during the last quarter. AlphaStar Capital Management LLC boosted its position in shares of BlackRock Health Sciences Trust by 6.9% in the second quarter. AlphaStar Capital Management LLC now owns 11,441 shares of the company’s stock valued at $417,000 after acquiring an additional 739 shares during the period. Finally, Shaker Financial Services LLC acquired a new stake in shares of BlackRock Health Sciences Trust in the second quarter worth $8,186,000.
BlackRock Health Sciences Trust Stock Down 0.2%
Shares of BME stock opened at $42.09 on Tuesday. BlackRock Health Sciences Trust has a 1 year low of $34.18 and a 1 year high of $42.51. The firm’s fifty day simple moving average is $41.52 and its 200 day simple moving average is $39.14.
BlackRock Health Sciences Trust Announces Dividend
BlackRock Health Sciences Trust Profile
BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.
Featured Stories
- Five stocks we like better than BlackRock Health Sciences Trust
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.
